EA202091923A1 - SUBSTITUTED TRICYCLIC COMPOUNDS AS FGFR INHIBITORS - Google Patents

SUBSTITUTED TRICYCLIC COMPOUNDS AS FGFR INHIBITORS

Info

Publication number
EA202091923A1
EA202091923A1 EA202091923A EA202091923A EA202091923A1 EA 202091923 A1 EA202091923 A1 EA 202091923A1 EA 202091923 A EA202091923 A EA 202091923A EA 202091923 A EA202091923 A EA 202091923A EA 202091923 A1 EA202091923 A1 EA 202091923A1
Authority
EA
Eurasian Patent Office
Prior art keywords
tricyclic compounds
substituted tricyclic
fgfr inhibitors
fgfr
inhibitors
Prior art date
Application number
EA202091923A
Other languages
Russian (ru)
Inventor
Лянсин У
Колин Чжан
Чуньхун Хэ
Япин Сунь
Лянь Лу
Дин-Цюань Цянь
Мэйчжун Сюй
Цзиньцун Чжо
Вэньцин Яо
Original Assignee
Инсайт Холдингс Корпорейшн
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Инсайт Холдингс Корпорейшн filed Critical Инсайт Холдингс Корпорейшн
Publication of EA202091923A1 publication Critical patent/EA202091923A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Настоящее изобретение относится к трициклическим соединениям формулы I и их фармацевтическим композициям, которые представляют собой ингибиторы одного или более ферментов FGFR и пригодны при лечении связанных с FGFR заболеваний, таких как рак.The present invention relates to tricyclic compounds of formula I and pharmaceutical compositions thereof, which are inhibitors of one or more FGFR enzymes and are useful in the treatment of FGFR-associated diseases such as cancer.

EA202091923A 2013-03-08 2013-06-12 SUBSTITUTED TRICYCLIC COMPOUNDS AS FGFR INHIBITORS EA202091923A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361774841P 2013-03-08 2013-03-08

Publications (1)

Publication Number Publication Date
EA202091923A1 true EA202091923A1 (en) 2020-11-05

Family

ID=73649879

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202091923A EA202091923A1 (en) 2013-03-08 2013-06-12 SUBSTITUTED TRICYCLIC COMPOUNDS AS FGFR INHIBITORS

Country Status (1)

Country Link
EA (1) EA202091923A1 (en)

Similar Documents

Publication Publication Date Title
PH12019502809A1 (en) Substituted tricyclic compounds as fgfr inhibitors
PH12019502810A1 (en) Bicyclic heterocycles as fgfr inhibitors
PH12017501817A1 (en) Heterocyclic compounds as lsd1 inhibitors
EA201791867A1 (en) BICYCLIC HETEROCYCLES AS FGFR4 INHIBITORS
EA201890239A2 (en) FUMARATES AS A DEVELOPMENT AND THEIR APPLICATION IN THE TREATMENT OF DIFFERENT DISEASES
EA201690316A1 (en) CONNECTIONS FOR USE AS IMMUNOMODULATORS
CR20200362A (en) CYCLOPROPYLAMINES AS LSD1 INHIBITORS (Divisional 2016-0395)
TR201901886T4 (en) DNA-PK inhibitors.
EA201691272A1 (en) TETRAHYDROPYRIDOPIRASINES AS GPR6 MODULATORS
EA201591728A1 (en) HETEROCYCLIC COMPOUNDS AND METHODS OF THEIR APPLICATION
EA201691032A1 (en) IZHOCHROMEN DERIVATIVES AS PHOSFOINOSYTID-3-KINAZ INHIBITORS
EA201692313A1 (en) Derivatives of indolysine as inhibitors of phosphosinositide-3-kinase
EA201500801A1 (en) BENZOHINOLONE INHIBITORS VMAT2
EA201590787A1 (en) SUBSTITUTED PYRIDOPYRAZINES AS SYK INHIBITORS
EA201690783A1 (en) SUBSTANCES, PHARMACEUTICAL COMPOSITION AND METHODS OF APPLICATION IN THE TREATMENT OF INFLAMMATORY DISEASES
EA201790207A1 (en) NEW SUBSTITUTED PYRIMIDINE COMPOUNDS
EA201270253A1 (en) DERIVATIVES N1-ACYL-5-FTORPYRIMIDINONA
MX2017007377A (en) Organic compounds.
EA201790070A1 (en) BIPHENYLAMIDE CONTAINING MODIFIED SIMPLE ETHER GROUPS AS HSP90 INHIBITORS AND HSP70 STIMULATORS
EA201690561A1 (en) Peptidylnitrile compounds as inhibitors of dipopeptidyl peptidase I
EA201600002A1 (en) DERIVATIVES OF SUBSTITUTED TRIAZOLOPIRIDINES
EA202091923A1 (en) SUBSTITUTED TRICYCLIC COMPOUNDS AS FGFR INHIBITORS
PH12016502133A1 (en) Substituted tricycle compounds as fgfr inhibitors